Parabilis Medicines Starts IPO On Promising Cancer Therapy Trials

🇺🇸 Seeking Alpha (US) —

AI Summary

Parabilis Medicines has initiated its IPO, leveraging promising results from cancer therapy trials. The move could signal an increased investor interest in biotechnology startups.

Deals Health AI & Tech Parabilis Medicines IPO cancer therapy biotechnology

Read original source →